America September 6, 2024
Bicara Therapeutics $200M IPO for Cancer Drug Development
Bicara Therapeutics Inc., a Boston-based clinical-stage biopharmaceutical company, announced on Friday its plans to raise approximately $200 million through an…
America September 6, 2024
Bicara Therapeutics Inc., a Boston-based clinical-stage biopharmaceutical company, announced on Friday its plans to raise approximately $200 million through an…
By Rihem Akkouche